Tyrogenex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Tyrogenex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tyrogenex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Tyrogenex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
26 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Tyrogenex, Inc. (Tyrogenex) formerly Xcovery, Inc., is a biopharmaceutical company that develops next generation targeted therapeutics for cancer. The companys products include clinical trials, VEGFR/PDGFR, c-Met, ALK, mTOR, PI3Kq and PI3K/mTOR. Tyrogenex has collaborations with the academic and clinical centers to validate the use of drug candidates in a number of disease indications and in various combinations. It also develops low toxicity molecular targeted oral drugs, which allow continuous therapy. The companys X-480 is a potent pan inhibitor of the pathway blocking signaling through both PI3K and mTOR. Tyrogenex is headquartered in West Palm Beach, Florida, the US

Tyrogenex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH140226D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Tyrogenex, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Tyrogenex, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Tyrogenex, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Tyrogenex, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Tyrogenex, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Tyrogenex, Inc., Pharmaceuticals &Healthcare, Deal Details1013
  Venture Financing101
    Tyrogenex Raises USD0.54 Million in Venture Financing101
    Xcovery Raises USD0.7 Million in Venture Financing111
    Tyrogenex Raises USD15 Million in Series D Venture Financing121
    Tyrogenex Raises US$8 Million In Venture Financing131
    Xcovery Raises US$2.4 Million In Venture Financing141
    Xcovery Raises US$2 Million In Venture Financing151
    Tyrogenex Raises US$3.3 Million In Venture Financing161
    Xcovery Raises US$6 Million In Series B Financing171
    Xcovery Holding Raises US$1.6 Million In Venture Financing181
    Tyrogenex Raises US$1.6 Million In Venture Financing191
    Tyrogenex Secures US$1 Million In Venture Financing201
    Xcovery Holding Secures US$2.4 Million In Venture Financing211
  Acquisition221
    Betta Pharma to Invest USD20 Million in Xcovery221
Tyrogenex, Inc. - Key Competitors231
Key Employees241
Locations And Subsidiaries251
  Head Office251
  Other Locations &Subsidiaries251
Appendix261
  Methodology261
  About GlobalData261
  Contact Us261
  Disclaimer261

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Tyrogenex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tyrogenex-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25012>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Tyrogenex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tyrogenex-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25012>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research